Trademark Overview
On Wednesday, May 10, 2017, a trademark application was filed for TRICEDRI with the United States Patent and Trademark Office. The USPTO has given the TRICEDRI trademark a serial number of 87445059. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 21, 2018. This trademark is owned by Seattle Genetics, Inc.. The TRICEDRI trademark is filed in the Pharmaceutical Products category with the following description:
PHARMACEUTICALS; PHARMACEUTICAL PREPARATIONS FOR USE IN HUMANS, NAMELY, CHEMOTHERAPEUTICS; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, AND THE GENITOURINARY SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISEASES, AND INFLAMMATORY DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, ONCOLOGY, HEMATOLOGY, OPHTHALMOLOGY, GASTROENTEROLOGY, AND TISSUE AND ORGAN TRANSPLANTOLOGY